Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Wells Fargo & Co (WFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Wells Fargo & Co — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.6 (market cap $30.93B), while Wells Fargo & Co trades at $81.6 (market cap $242.83B). The key difference: Wells Fargo & Co is far larger — about 7.9× GE HealthCare Technologies Inc. Common Stock's market cap, and Wells Fargo & Co pays the higher dividend (2.47%). Which is the better fit depends on your goals.
| GEHC | WFC | |
|---|---|---|
Market Cap | $30.93B | $242.83B |
Volume | 5,033,451 | 21,447,763 |
Sector | Health | Financials |
52-Week High | $88.16 | $96.40 |
52-Week Low | $59.48 | $73.42 |
Enterprise Value | $39.39B | $425.14B |
Dividend Yield | 0.23% | 2.47% |
Typical Hold Time | — | 88 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Wells Fargo (WFC) trades at $80.74, down 3.07% today, with a bullish technical signal but mixed indicators. The stock shows strong profitability with a 25.97% net income margin and trades at a P/E of 11.74, below the industry average. Recent earnings beat expectations in two of the last three quarters, and a credit rating upgrade to 'A-' by S&P on October 1, 2026, reflects improved risk management.
The outlook is positive with a consensus price target of $98, implying 21% upside, supported by stable Fed stress tests and potential net interest income growth from rate hikes. Risks include volatile cash flows, with operating cash flow negative in 2025, and sensitivity to economic cycles. Institutional sentiment is balanced with 47% buy and hold ratings each.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Wells Fargo & Co
Wells Fargo is one of the largest banks in the United States, with approximately $1.9 trillion in balance sheet assets. The company is split into four primary segments: consumer banking, commercial banking, corporate and investment banking, and wealth and investment management. It is almost entirely focused on the U.S.
Read more on WFC →
